HIGHLIGHTS
- who: . and collaborators from the Beijing Institute of Microbiology and Epidemiology, China Huazhong University of Science and have published the research work: Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study, in the Journal: (JOURNAL) of 19/Dec/2019
- what: Inspired by the above studies suggesting that ambroxol may have an inhibitory effect on SARS-CoV-2, it may be hypothesized that ambroxol may be useful in improving COVID-19 patient outcomes, so this retrospective study was conducted to explore the effects of ambroxol on COVID-19 patient outcomes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.